You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
EXPERIENCE WITH DOXORRUBICIN DRUG-ELUTING BEADS IN HEPATIC CHEMOEMBOLIZATION
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-040
- By: GARCIA SACRISTAN, Ana Andrea (Virgen de la salud Hospital, PHARMACY, Spain)
- Co-author(s): Ana Andrea Garcia Sacristan: PHARMACY, Virgen de la salud Hospital, toledo, Spain;PHARMACY, Virgen de la salud Hospital, toledo, Spain
Ana Dominguez Barahona: PHARMACY, Virgen de la salud Hospital, toledo, Spain
Silvia González Suárez : PHARMACY, Virgen de la salud Hospital, toledo, Spain
Raul López Álvarez: PHARMACY, Virgen de la salud Hospital, toledo, Spain
Nuria Labrador Andújar: PHARMACY, Virgen de la salud Hospital, toledo, Spain
Paloma Moya Gómez: PHARMACY, Virgen de la salud Hospital, toledo, Spain;PHARMACY, Virgen de la salud Hospital, toledo, Spain - Abstract:
Background
Hepatic chemoemobolization with doxorrubicin drug-eluting beads (DDEB) is a type of local therapy for patients with hepatocellular carcinoma with localised nodules,not suitable for surgery.Methods
Retrospective, descriptive study of patients treated with DDEB from September 2015-December 2018 in a teaching hospital. Data were taken
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026